A Multicenter Study to Evaluate Functional Outcome After Knee Replacement
| Status: | Recruiting | 
|---|---|
| Conditions: | Arthritis, Osteoarthritis (OA) | 
| Therapuetic Areas: | Rheumatology | 
| Healthy: | No | 
| Age Range: | 18 - Any | 
| Updated: | 11/4/2018 | 
| Start Date: | July 1, 2015 | 
| End Date: | June 2029 | 
| Contact: | Marc Quartulli | 
| Email: | marc.quartulli@conformis.com | 
| Phone: | 781-345-9191 | 
A Prospective, Multicenter Study to Evaluate Functional Outcome After Knee Replacement
Patients will be consecutively enrolled by implant. Implant groups will be those who have
undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the- Shelf (OTS) system.
The patient will conduct functional testing and answer questionnaires.
The results will compare the ConforMIS iTotal with an Off the Shelf Knee replacement.
			undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the- Shelf (OTS) system.
The patient will conduct functional testing and answer questionnaires.
The results will compare the ConforMIS iTotal with an Off the Shelf Knee replacement.
To compare functional and patient reported outcome data for a consecutively enrolled group of
subjects who have undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the-
Shelf (OTS) system.The person conducting the functional testing will be blinded to the device
implanted. Sites will perform the off-the-shelf total knees conventional instrumentation.
subjects who have undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the-
Shelf (OTS) system.The person conducting the functional testing will be blinded to the device
implanted. Sites will perform the off-the-shelf total knees conventional instrumentation.
Inclusion:
- Clinical condition included in the approved Indications For Use for the iTotal CR
- Osteoarthritis, as confirmed by the investigator's assessment of disease status at
screening visit that warrants a TKR procedure. Disease status is assessed by Clinical
and Radiographic assessment
- Willingness to participate in the clinical study, to give informed consent and to
attend all follow-up visits
- > 18 years of age
Exclusion:
- Subject will require a simultaneous bilateral procedure
- Other lower extremity surgery within 1 year
- Severe (> 15º) fixed valgus or varus deformity
- Severe (> 15º) extension deficit
- Severe instability due to advanced loss of osteochondral structure
- Loss of bone or musculature, osteoporosis, neuromuscular or vascular compromise in the
area of the joint to be operated on to an extent that the procedure is unjustified
- Insufficient bone stock on the femoral or tibial surfaces
- Contralateral knee replacement surgery within the past 6 months
- BMI > 40
- Active malignancy (defined as a history of any invasive malignancy - except
non-melanoma skin cancer), unless patient has been treated with curative intent and
there have been no clinical signs or symptoms of the malignancy for at least 5 years
- Poorly controlled diabetes (defined as HbA1c >7 or surgeon discretion)
- Immunocompromised
- Other physical disability affecting the hips, spine, or contralateral knee that limits
function
- Disabling chronic pain with narcotic dependence
- Compromised PCL or collateral ligament
- Prior history of failed implant surgery of the joint to be treated, including
Unicompartmental Knee Arthroplasty (UKA), or Bicompartmental Knee Arthroplasty (BKA)
- Prior history of failed high tibial osteotomy (HTO)
- Participation in another clinical study which would confound results
- Inability to complete the protocol in the opinion of the clinical staff due to safety
or other reasons
We found this trial at
    8
    sites
	Click here to add this to my saved trials
	
								Boston, Massachusetts 02111			
	
			
					Principal Investigator: Eric Smith, MD
			
						
										Phone: 617-636-5159
					Click here to add this to my saved trials
	
								Cincinnati, Ohio 45219			
	
			
					Principal Investigator: Michael Swank, MD
			
						
										Phone: 513-585-1777
					Click here to add this to my saved trials
	
								Columbia, Missouri 65211			
	
			(573) 882-2121
							
					Principal Investigator: Thomas J Aleto, MD
			
						
										Phone: 573-882-2663
					
		University of Missouri T he University of Missouri was founded in 1839 in Columbia, Mo.,...  
  
  Click here to add this to my saved trials
	
									9500 Gilman Dr
La Jolla, California 92093
	
			La Jolla, California 92093
(858) 534-2230
							
					Principal Investigator: Scott Ball, MD
			
						
										Phone: 858-210-8727
					
		The University of California, San Diego UC San Diego is an academic powerhouse and economic...  
  
  Click here to add this to my saved trials
	
								New Haven, Connecticut 06520			
	
			
					Principal Investigator: Mary O'Connor, MD
			
						
										Phone: 203-737-2843
					Click here to add this to my saved trials
	
								Parker, Colorado 80134			
	
			
					Principal Investigator: Derek R Johnson, MD
			
						
										Phone: 303-214-4500
					Click here to add this to my saved trials
	
								San Diego, California 32123			
	
			
					Principal Investigator: Richard Coutts, MD
			
						
										Phone: 858-499-5026
					Click here to add this to my saved trials